Anticoagulants


Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.

There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.

Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.

While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.

In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.

NameCAS numberCategoryAmount of suppliers
1-Methoxydecane1120-21-4Antithrombotics1
Abciximab143653-53-6Glycoprotein IIb/IIIa receptor antagonists1
Acenocoumarol152-72-7Other antithrombin7
Acetazolamide59-66-5Carbonic anhydrase(II) inhibitors12
Aesculin66778-17-4Anticoagulant proteins2
Apixaban503612-47-3Antithrombotics58
Argatroban74863-84-6Anticoagulant proteins16
Astaxanthin472-61-7Anticoagulants2
Betrixaban330942-05-7Anticoagulants0
Bivalirudin128270-60-0Antithrombotics19
Calaspargase pegol941577-06-6Anticoagulants0
Cangrelor163706-06-7Antithrombotics3
Carbazochrome sulfonic acid70063-04-6Anticoagulants0
Cilengitide188968-51-6Other antithrombin1
Cilostazol73963-72-1Antithrombotics24
Cinnamic acid140-10-3Anticoagulants0
Clorindione1146-99-2Anticoagulants0
Coumarin91-64-5Anticoagulants0
Dabigatran211914-51-1Anticoagulants0
Dabigatran etexilate211915-06-9Direct thrombin inhibitors42
Dalteparin9005-49-6Heparins6
Danaparoid308068-55-5Anticoagulants0
Dermatan sulfate24967-94-0Anticoagulants0
Diphenadione82-66-6Anticoagulants0
Dociparstat sodium177021-00-0Anticoagulants0
Dorzolamide120279-96-1Carbonic anhydrase(II) inhibitors23
Edoxaban480449-70-5Antithrombotics15
Eltrombopag496775-61-2Other antithrombin9
Enoxaparin9005-49-6Heparins22
Eptifibatide188627-80-7Glycoprotein IIb/IIIa receptor antagonists21
Fluindione957-56-2Anticoagulant proteins2
Fondaparinux sodium114870-03-0Antithrombotics15
Gabexate39492-01-8Anticoagulants0
Heparin calcium37270-89-6Anticoagulant proteins10
Heparin sodium9005-49-6Anticoagulant proteins43
HeparinoidAnticoagulant proteins1
Idraparinux162610-17-5Anticoagulants0
Kappadione131-13-5Anticoagulant proteins1
Lepirudin138068-37-8Direct thrombin inhibitors2
Letaxaban870262-90-1Anticoagulants0
Menaquinone1182-68-9Anticoagulants0
Menaquinone 684-81-1Anticoagulants0
Menaquinone 72124-57-4Anticoagulants0
Methazolamide554-57-4Carbonic anhydrase(II) inhibitors5
Nadroparin9041-08-1Heparins4
Parnaparin91449-79-5Heparins3
Phenprocoumon435-97-2Other antithrombin3
Potassium triiodide12298-68-9Anticoagulants0
Prasugrel150322-43-3Antithrombotics25
Protocatechualdehyde139-85-5Anticoagulants0
Rivaroxaban366789-02-8Antithrombotics73
Romiplostim267639-76-9Other antithrombin1
SG31991595275-71-0Other antithrombin1
Sodium Citrate68-04-2Anticoagulant proteins12
Streptokinase9002-01-1Thrombolytics1
Sulodexide57821-29-1Antithrombotics4
Tenecteplase191588-94-0Thrombolytics1
Tioclomarol22619-35-8Anticoagulants0
Tirofiban144494-65-5Glycoprotein IIb/IIIa receptor antagonists8
Tocopherylquinone7559-04-8Anticoagulants0
Urokinase9039-53-6Thrombolytics1
Vorapaxar618385-01-6Other antithrombin1
Warfarin81-81-2Other anticoagulants22